Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Verastem, Inc. Director's Dealing 2014

Jan 3, 2014

32713_dirs_2014-01-03_f9bcf38c-976e-42fc-b67f-618538000ae1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Verastem, Inc. (VSTM)
CIK: 0001526119
Period of Report: 2014-01-02

Reporting Person: Westphal Christoph H (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-01-02 Common Stock F 6492 $11.40 Disposed 690380 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2869841 Indirect
Common Stock 125714 Indirect

Footnotes

F1: Shares withheld by Registrant to satisfy statutory withholding requirements upon vesting of restricted stock units.

F2: Represents 587,076 shares of common stock and 103,304 restricted stock units.

F3: Longwood Fund GP, LLC is the sole General Partner of Longwood Fund, L.P. Christoph Westphal, M.D., Ph.D., Richard Aldrich and Michelle Dipp, M.D., Ph.D. (collectively, the "Managers") are managers of Longwood Fund GP, LLC, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held by Longwood Fund L.P. (the "Longwood Shares"). Each of the Managers disclaims beneficial ownership of the Longwood Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of the Longwood Shares in this report shall not be deemed an admission of beneficial ownership of the Longwood Shares for purposes of Section 16 or for any other purpose.